Strax

Autospela

MRD’s Potential Role in Treating Acute Myeloid Leukemia

0 Visningar • 07/04/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

Harry Erba, MD, PhD; Alexander E. Perl, MD; Eunice Wang, MD; and Jorge E. Cortes, MD, debate the current value of minimal residual disease testing for therapeutic decision-making in acute myeloid leukemia and identify the needs to be addressed before use in standard practice.

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela